Biological Therapy Analysis & Statistics in the United States, November 2014

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

Publishers

  • All
    • Global Data

All regions

You might be interested in: Stem Cell, Tissue Engineering, Cell Therapy, more »

1-30 of 59 reports

Purchase Reports From Reputable Market Research Publishers

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData's report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, Japan, India, China, Asia, World
Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the research and development (R&D) of novel immunotherapies for the treatment of cancer. The ...

  • Industries : Biological Therapy
  • Countries : United States
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

GENova Biotherapeutics, Inc. (Symbol:GVBP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

Viropro Inc. (Symbol:VPRO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. ...

  • Industries : Biological Therapy
  • Countries : Australia, Singapore, United States
Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

Stem Cell Innovations, Inc. (SCLL) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Stem Cell Innovations, Inc. (SCI) is a privately held biotechnology company, based in the US. The company is engaged in the discovery and development of human cell based drugs. Its core technologies ...

  • Industries : Biological Therapy
  • Countries : United States
AmStem Corporation (Symbol:AMST) SWOT Analysis, Strategy, Revenues and Profits

AmStem Corporation (Symbol:AMST) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company's services include cell therapy. Its cell therapy is developing a novel cell-based therapy ...

  • Industries : Biological Therapy
  • Countries : United States
Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Forticell Bioscience, Inc. (Forticell) is a biotechnology company. The company develops natural biomaterials and tissue engineered cellular therapies. Its product OrCel is used to stimulate the ...

  • Industries : Biological Therapy
  • Countries : United States
Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Protide Pharmaceuticals, Inc. (Protide) is a biotechnology company. The company develops and commercializes technologies and processes in clinical cell therapy, regenerative medicine, transfusion ...

  • Industries : Biological Therapy
  • Countries : United States
Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary bluebird bio, Inc. (bluebird bio) is a biotechnology company. The company develops gene therapies for severe genetic and orphan diseases. Its products include LentiGlobin, Lenti D, and CAR T cells. ...

  • Industries : Biological Therapy
  • Countries : United States
Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Medistem, Inc. (Medistem) is a biotechnology company. The company operates in the field of discovery, development and commercialization of biological technologies. Its technologies are related ...

  • Industries : Biological Therapy
  • Countries : United States
California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Stem Cell, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary California Stem Cell, Inc. (CSC) is a biotechnology company. The company produces and supplies clinically relevant human cell populations and therapeutic application to human disease and injury. ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Medistem, Inc. (MEDS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Medistem, Inc. (MEDS)

  • $ 250
  • Company report
  • July 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
DiscoveryBiomed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DiscoveryBiomed, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary DiscoveryBiomed, Inc. (DBM) is a life sciences and biotechnology company. The company discovers and develops human cell based drugs. It offers products in three segments, such as cell cultures, ...

  • Industries : Biological Therapy
  • Countries : United States
Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bellicum Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a biopharmaceutical company. The company develops novel cellular immunotherapies for the treatment of cancer. The company is developing new modes of ...

  • Industries : Biological Therapy
  • Countries : United States
Capricor Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Capricor Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Capricor Inc. (Capricor) is a biotechnology company. The company develops and commercializes cardiac stem cell therapeutics to replace cells, which are damaged due to chronic and acute heart disease. ...

  • Industries : Biological Therapy
  • Countries : United States
Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cyntellect, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cyntellect, Inc. (Cyntellect) is a life science company based in the US. The company provides standards for advancing the fields of cell analysis. Its products include celigo and c-lect consumables. ...

  • Industries : Biological Therapy
  • Countries : United States
Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellartis AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Cellartis AB (Cellartis) is a biotechnology company. The company provides pluripotent stem cells and human embryonic stem cells, and technology for drug discovery research, toxicity testing and ...

  • Industries : Biological Therapy
  • Countries : United States
MaxCyte, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MaxCyte, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary MaxCyte, Inc. (MaxCyte) is a biotherapeutics company. The company offers cell-based therapies for chronic and acute diseases. It offers products such as MaxCyte STX, MaxCyte VLX and MaxCyte GT. ...

  • Industries : Biological Therapy
  • Countries : United States
Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lentigen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary Lentigen Corporation (Lentigen) is a biotechnology company. The company develops and commercializes lentiviral vector technology for a range of therapeutic, vaccine, and bioproduction applications. ...

  • Industries : Biological Therapy
  • Countries : United States
GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GENova Biotherapeutics, Inc. (GVBP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary GENova Biotherapeutics, Inc. (GENova) is a publicly traded biotechnological drug development company, engaged in the identifying, evaluating and acquiring drugs for treatment of oncological and ...

  • Industries : Biological Therapy
  • Countries : United States
International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Stem Cell Corporation (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company. The company develops parthenogenesis, a stem cell technology that advances the field of regenerative medicine. It develops ...

  • Industries : Biological Therapy
  • Countries : India, United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It has developed a regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

Aastrom Biosciences, Inc. (Symbol:ASTM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2014
  • by Global Data

BioTime, Inc. (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Biological Therapy
  • Countries : United States
About 200 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Supply in the US

  • September 2014
    11 pages
  • Biological Ther...  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.